Main menu button

Actualités

Equity research Teneo AI, Q3 2024: Excellent growth driven by increased volumes
25 Oct 2024
Equity research Teneo AI, Q3 2024: Excellent growth driven by increased volumes
Equity Research Teneo AI
Equity Research Enrad, Q3 2024: Sales in line with expectations, but better than expected gross margin
25 Oct 2024
Equity Research Enrad, Q3 2024: Sales in line with expectations, but better than expected gross margin
Equity Research Enrad
Carlsquare Equity Research: Real Estate Equity Snapshot
21 Oct 2024
Carlsquare Equity Research: Real Estate Equity Snapshot
Equity Research ALM Equity
Equity research, Viva Wine Group: We expect solid performance in a slow market in Q3 2024
21 Oct 2024
Equity research, Viva Wine Group: We expect solid performance in a slow market in Q3 2024
Equity Research Viva Wine Group
Carlsquare Weekly Market Letter: Christmas has come early for stock traders this year
09 Oct 2024
Carlsquare Weekly Market Letter: Christmas has come early for stock traders this year
Equity Research
Equity research, Zinzino: On track to achieve growth target
04 Oct 2024
Equity research, Zinzino: On track to achieve growth target
Equity Research Zinzino
Carlsquare weekly market letter: China took the lead – what’s next?
02 Oct 2024
Carlsquare weekly market letter: China took the lead – what’s next?
Equity Research Carlsquare
Carlsquare weekly market letter: Is China finally taking off?
25 Sep 2024
Carlsquare weekly market letter: Is China finally taking off?
Equity Research Carlsquare
Carlsquare Equity Research interview with Biosergen
23 Sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research Biosergen
Carlsquare weekly market letter: Another leg down – or time for small caps?
18 Sep 2024
Carlsquare weekly market letter: Another leg down – or time for small caps?
Equity Research Carlsquare
Carlsquare Equity Research: Swedish consumer sector snapshot
16 Sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Equity Research Viva Wine Group
Research update Biosergen: First patient treated in phase Ib study a success
12 Sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research Biosergen
Carlsquare weekly market letter: How to deal with a stormy market
11 Sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research Carlsquare
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
09 Sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Equity Research Svenska Aerogel
Equity research Zinzino: Making a late summer splash
05 Sep 2024
Equity research Zinzino: Making a late summer splash
Equity Research Zinzino
Carlsquare weekly market letter: Time for a new bump in the road?
04 Sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Equity Research Carlsquare
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
03 Sep 2024
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
Equity Research Enrad
Equity research Zinzino: Robust profit growth despite lower gross margin in Q2 2024
02 Sep 2024
Equity research Zinzino: Robust profit growth despite lower gross margin in Q2 2024
Equity Research Zinzino
Equity research Enrad, Q2 2024: Very strong quarter
30 Août 2024
Equity research Enrad, Q2 2024: Very strong quarter
Equity Research Enrad
Equity research Zinzino: Profit growth despite pressure on gross margin in Q2 2024
30 Août 2024
Equity research Zinzino: Profit growth despite pressure on gross margin in Q2 2024
Equity Research Zinzino